Baird Medical Investment Holdings Limited
BDMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $194,219 | $81,222 | $64,498 | $70,869 |
| - Cash | $2,970 | $1,510 | $1,711 | $3,032 |
| + Debt | $20,877 | $9,900 | $7,441 | $2,935 |
| Enterprise Value | $212,126 | $89,611 | $70,228 | $70,771 |
| Revenue | $37,037 | $31,458 | $35,091 | $27,722 |
| % Growth | 17.7% | -10.4% | 26.6% | – |
| Gross Profit | $32,654 | $27,230 | $28,037 | $23,178 |
| % Margin | 88.2% | 86.6% | 79.9% | 83.6% |
| EBITDA | $16,171 | $12,876 | $16,291 | $14,159 |
| % Margin | 43.7% | 40.9% | 46.4% | 51.1% |
| Net Income | $12,453 | $10,546 | $12,569 | $11,677 |
| % Margin | 33.6% | 33.5% | 35.8% | 42.1% |
| EPS Diluted | 0.49 | 0.41 | 0.022 | -0.024 |
| % Growth | 19.5% | 1,789.4% | 189.7% | – |
| Operating Cash Flow | -$6,313 | -$1,020 | $486 | $5,255 |
| Capital Expenditures | -$2,854 | -$2,638 | -$5,954 | -$1,388 |
| Free Cash Flow | -$9,167 | -$3,658 | -$5,468 | $3,867 |